↓ Skip to main content

Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind…

Overview of attention for article published in BMC Psychiatry, October 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
106 Mendeley
Title
Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study
Published in
BMC Psychiatry, October 2013
DOI 10.1186/1471-244x-13-253
Pubmed ID
Authors

Lenard A Adler, Bryan Dirks, Patrick Deas, Aparna Raychaudhuri, Matthew Dauphin, Keith Saylor, Richard Weisler

Abstract

This study examined the effects of lisdexamfetamine dimesylate (LDX) on quality of life (QOL) in adults with attention-deficit/hyperactivity disorder (ADHD) and clinically significant executive function deficits (EFD).

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Brazil 1 <1%
Unknown 103 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 18 17%
Student > Ph. D. Student 14 13%
Student > Master 11 10%
Student > Postgraduate 9 8%
Researcher 7 7%
Other 29 27%
Unknown 18 17%
Readers by discipline Count As %
Psychology 28 26%
Medicine and Dentistry 25 24%
Neuroscience 6 6%
Nursing and Health Professions 5 5%
Social Sciences 5 5%
Other 15 14%
Unknown 22 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2013.
All research outputs
#12,368,035
of 19,561,582 outputs
Outputs from BMC Psychiatry
#2,737
of 4,073 outputs
Outputs of similar age
#102,575
of 184,022 outputs
Outputs of similar age from BMC Psychiatry
#1
of 1 outputs
Altmetric has tracked 19,561,582 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,073 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 184,022 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them